WellPoint, Inc. — 2012 Form 10-K
Reporting period and entity: The supplied filing is WellPoint, Inc.’s annual report for the fiscal year ended December 31, 2012—not a standalone Q4 filing. This differs from the request metadata naming Elevance Health, Inc.; the filing identifies the registrant as WellPoint, Inc. It reports Q4 results within its annual statements. Unless otherwise noted, dollar amounts below are in millions.
Business context and reporting period
WellPoint operated health benefit plans and related services across commercial, consumer, and other businesses, including Medicare, Medicaid, federal programs, and—following its June acquisition—1-800 CONTACTS. It served 36.1 million medical members at year-end, up 5.5% from 2011, largely due to acquired Amerigroup membership. The Amerigroup acquisition closed December 24, 2012; its post-close contribution was limited.
Key financial results
| Metric | 2012 | 2011 | Change |
|---|---|---|---|
| Operating revenue | $60,728.5 | $59,865.2 | +1.4% |
| Total revenue | $61,711.7 | $60,710.7 | +1.6% |
| Net income | $2,655.5 | $2,646.7 | +0.3% |
| Diluted EPS | $8.18 | $7.25 | +12.8% |
| Adjusted net income | $2,456.1 | $2,554.5 | -3.9% |
| Adjusted diluted EPS | $7.56 | $7.00 | +8.0% |
| Benefit expense ratio | 85.3% | 85.1% | +20 basis points |
| SG&A expense ratio | 14.4% | 14.1% | +30 basis points |
| Operating cash flow | $2,744.6 | $3,374.4 | -$629.8 |
Reported EPS benefited substantially from a lower diluted share count following repurchases; average diluted shares declined 11.0%. Adjusted results exclude specified items, including investment gains and losses, litigation and acquisition-related costs, and tax settlements. The filing says revenue growth reflected expansion in Senior and State-Sponsored businesses, partly offset by Commercial membership declines.
Q4 snapshot: Total revenue was $15,536.1 versus $15,317.7 in Q4 2011; net income was $464.2 versus $335.3; diluted EPS was $1.51 versus $0.96. Quarterly results are unaudited.
Segments and balance sheet
- Commercial: Revenue $33,553.5, down 2.7%; operating gain $3,199.7, up 3.5%. Operating margin rose to 9.5% from 9.0%, reflecting improved Local Group results and ancillary-business contributions.
- Consumer: Revenue $19,427.7, up 9.2%; operating gain fell 29.4% to $440.2, with margin declining to 2.3% from 3.5%, reflecting higher State-Sponsored and Individual costs and acquisition/restructuring expenses.
- Other: Revenue $7,747.3, up 2.2%; operating loss was $0.7, versus operating gain of $68.5 in 2011, partly due to unallocated costs and litigation expenses.
- Year-end total assets were $58,955.4, total liabilities $35,152.7, and shareholders’ equity $23,802.7. Cash, cash equivalents, and investments, including long-term investments, totaled $22,474.0.
- Total debt was approximately $14,977.9. The debt-to-capital ratio increased to 38.6% from 29.7%, above management’s 25%–35% target range. The company said it expected the ratio to return to its target range over time.
- Available liquidity included a $2,000.0 undrawn revolving credit facility and a $2,500.0 commercial paper program, of which $570.9 was outstanding. Parent-company cash and investments available for general corporate use were $2,029.0.
Material changes versus 2011
- Amerigroup’s acquisition added 2.662 million State-Sponsored members; total State-Sponsored membership rose 144.3%. Amerigroup contributed $219.0 of post-acquisition operating revenue and a $6.1 net loss in 2012.
- 1-800 CONTACTS, acquired June 20, contributed $214.5 of post-acquisition operating revenue and $12.9 of net income.
- Commercial membership declined, including Local Group down 3.8% and National Accounts down 5.4%; total Commercial membership fell 3.3%. Senior membership rose 5.0%.
- Operating cash flow declined 18.7%, primarily due to former-member claims run-out, Amerigroup post-acquisition cash outflows, litigation settlement payments, and minimum medical loss ratio rebate payments.
- Debt increased following acquisition financing. WellPoint issued $5.5 billion of notes during 2012 and $1.5 billion of convertible debentures; share repurchases totaled $2,496.8, down from $3,039.8 in 2011.
Outlook, risks, contingencies, and unusual items
- Outlook: No specific forward earnings or EPS guidance is provided in the supplied filing text. Management expected unemployment to remain relatively high during 2013, potentially pressuring membership, and expected self-funded plans to increase as a share of group membership. It cited a 2012 Local Group fully insured cost-of-care trend near the low end of 7.0%, plus or minus 50 basis points, and planned to expand value-based provider programs.
- Health reform: Management said the effects of the ACA remained uncertain, particularly as major provisions—including exchanges, Medicaid expansion, new rating rules, and industry fees—were scheduled to take effect in 2014. Potential impacts include pricing constraints, adverse selection, reimbursement changes, and additional compliance costs.
- Claims reserves: Medical claims payable were $6,174.5 at year-end. The company recognized $513.6 of favorable prior-year claims reserve development in 2012. Management identified completion and trend assumptions as significant estimation risks.
- Unusual items: A $200.5 income tax benefit arose from IRS settlements and related tax matters. A $90.0 settlement in the Ormond demutualization lawsuit was recorded in 2012; the filing notes appeals by objectors. Adjusted results also exclude $106.4 of acquisition and integration costs and $24.0 of litigation-related costs.
- Legal and other contingencies: The company estimated reasonably possible losses above established reserves of $0 to approximately $350.0 for proceedings where an estimate was feasible. Potential Penn Treaty guaranty-fund assessments could not be estimated and could be material. Goodwill and other intangible assets totaled $26,613.3; no impairment was recorded in 2012, but management warned future impairment was possible.
- Other risks: Key exposures include government-program funding and contract compliance, medical cost and pricing accuracy, membership and product mix, integration of acquisitions, investment-market volatility, cybersecurity and systems dependence, regulatory limits on subsidiary dividends, and substantial indebtedness.
- The independent auditor issued an unqualified opinion on the financial statements and internal control over financial reporting. Management’s control assessment excluded acquired Amerigroup operations; the auditor likewise did not evaluate those controls.
Important facts for investors to verify
- Confirm the registrant and period: this is WellPoint’s FY2012 10-K, not an Elevance Health filing or a standalone Q4 report.
- Assess underlying earnings quality: reported net income was nearly flat, while adjusted net income declined; quantify the effects of tax settlements, investment gains, reserve development, and share repurchases.
- Track Consumer segment margins and medical costs, especially acquired Medicaid membership and its profitability as Amerigroup integration proceeds.
- Review debt repayment capacity and the path back to the stated 25%–35% debt-to-capital target, including post-year-end redemption of Amerigroup notes.
- Monitor the resolution of litigation, Penn Treaty exposure, ACA implementation, and the assumptions supporting the $6.2 billion medical claims reserve and $26.6 billion of goodwill and other intangibles.